Point-of-Care/Rapid Diagnostics Market by Testing, Platform, Mode & End-User – Global Forecast to 2022

Dublin, Feb. 27, 2018 (GLOBE NEWSWIRE) -- The "Point-of-Care/Rapid Diagnostics Market by Testing (Glucose, Lipids, HbA1c, HCV, HIV, Influenza, Urinalysis, Hematology, Cancer, Pregnancy, PT/INR), Platform (Lateral Flow, Immunoassay), Mode (Prescription, OTC), End-User - Global Forecast to 2022" report has been added to ResearchAndMarkets.com's offering.

The global point-of-care diagnostics market is projected to reach USD 38.13 Billion by 2022 from USD 23.71 Billion in 2017, at a CAGR of 10.0% during the forecast period.

Factors such as high prevalence of infectious diseases in developing countries, increasing incidence of target diseases, and rising preference for home healthcare across the globe are increasing the adoption of POC diagnostic products globally.

This report broadly segments the rapid diagnostic market into product, platform, mode, end user, and region.

The report covers the point-of-care diagnostics market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to command the largest share of the market in 2017, due to the growing prevalence of lifestyle diseases, increasing number of product approvals, and rising government initiatives in this region.

The major players of the market

  • Abbott Laboratories
  • Accubiotech
  • Becton, Dickinson, and Company (BD)
  • Chembio Diagnostics
  • Danaher Corporation
  • EKF Diagnostics
  • Instrumentation Laboratory (A Werfen Company)
  • Johnson & Johnson
  • Nova Biomedical
  • PTS Diagnostics (A Part of Sinocare Inc.)
  • Quidel
  • Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche Ltd.)
  • Sekisui Diagnostics
  • Siemens
  • Trinity Biotech

Market Dynamics


  • High Prevalence of Infectious Diseases in Developing Countries
  • Increasing Incidence of Target Diseases
  • Rising Usage of Home-Based POC Devices
  • Growing Government Support
  • Technological Advancements and New Product Launches
  • Growing Number of Regulatory Approvals for Novel Immunoassay Techniques
  • Shortage of Skilled Laboratory Technicians
  • Rising Number of Clia-Waived POC Tests


  • Product Recalls: Hampering User Confidence
  • Pricing Pressure Owing to Reimbursement Cuts and Budget Constraints
  • Stringent and Time-Consuming Regulatory Policies are Significantly Increasing Gestation Period for Product Launches


  • Growth Opportunities in Emerging Markets
  • Healthcare Decentralization - Converting Lab Tests to POC Tests
  • Increasing Number of Conferences and Events
  • POC Tests With Multiplexing Capabilities


  • Lack of Alignment With Definitive Central Lab Methods
  • Inadequate Knowledge About the Use of POC Devices in Professional Settings
  • Reluctance Towards Changing Existing Diagnostic Practices
  • High Cost of Devices

Emerging Applications of Point-of-Care Testing

  • Sepsis Biomarkers
  • Stroke Markers
  • Thyroid Testing
  • Dna Testing
  • Endocrine Testing

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Point-of-Care Diagnostics Market, By Product

7 Point-of-Care Diagnostics Market, By Platform

8 Point-of-Care Diagnostics Market, By Prescription Mode

9 Point-of-Care Diagnostics Market, By End User

10 Point-of-Care Diagnostics Market, By Region

11 Competitive Landscape

12 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/s54flj/pointofcarerapi?w=12


CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         Related Topics: Point-of-Care Diagnostics